Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Truebel

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Environmental Research and Public Health|July 27, 2022
Healthcare Providers' Knowledge of Value-Based Care in Germany: An Adapted, Mixed-Methods ApproachAxel Kuck, Kristian Kinscher, Leonard Fehring, et al.
European Journal of Applied Physiology|March 10, 2019
A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstructionHubert Truebel, Sandra Wuester, Philip Boehme, et al.
American Journal of Therapeutics|December 31, 2010
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure modelThomas Mondritzki, Peter Kolkhof, Hani N Sabbah, et al.
Plos One|September 10, 2013
Effects of different pulmonary vasodilators on arterial saturation in a model of pulmonary hypertensionEva Maria Becker, Johannes-Peter Stasch, Martin Bechem, et al.
Nature Reviews. Drug Discovery|October 4, 2022
Predictive validity in drug discovery: what it is, why it matters and how to improve itJack W Scannell, James Bosley, John A Hickman, et al.
European Journal of Heart Failure|September 18, 2020
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failureThomas Mondritzki, Thuy Anh Mai, Julia Vogel, et al.
Journal of Pharmacological and Toxicological Methods|November 18, 2023
Telemetric long-term assessment of autonomic function in experimental heart failureKatharina Boden, Pailin Pongratanakul, Julia Vogel, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 22, 2021
sGC stimulation lowers elevated blood pressure in a new canine model of resistant hypertensionJulia Vogel, Philip Boehme, Susanne Homann, et al.
European Journal of Applied Physiology|November 22, 2017
New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventionsThomas Mondritzki, Philip Boehme, Lena Schramm, et al.
Journal of Cardiovascular Pharmacology|July 6, 2019
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor AntagonistPeter Kolkhof, Elisabeth Pook, Mira Pavkovic, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Environmental Research and Public Health|July 27, 2022
Healthcare Providers' Knowledge of Value-Based Care in Germany: An Adapted, Mixed-Methods ApproachAxel Kuck, Kristian Kinscher, Leonard Fehring, et al.
European Journal of Applied Physiology|March 10, 2019
A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstructionHubert Truebel, Sandra Wuester, Philip Boehme, et al.
American Journal of Therapeutics|December 31, 2010
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure modelThomas Mondritzki, Peter Kolkhof, Hani N Sabbah, et al.
Plos One|September 10, 2013
Effects of different pulmonary vasodilators on arterial saturation in a model of pulmonary hypertensionEva Maria Becker, Johannes-Peter Stasch, Martin Bechem, et al.
Nature Reviews. Drug Discovery|October 4, 2022
Predictive validity in drug discovery: what it is, why it matters and how to improve itJack W Scannell, James Bosley, John A Hickman, et al.
European Journal of Heart Failure|September 18, 2020
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failureThomas Mondritzki, Thuy Anh Mai, Julia Vogel, et al.
Journal of Pharmacological and Toxicological Methods|November 18, 2023
Telemetric long-term assessment of autonomic function in experimental heart failureKatharina Boden, Pailin Pongratanakul, Julia Vogel, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 22, 2021
sGC stimulation lowers elevated blood pressure in a new canine model of resistant hypertensionJulia Vogel, Philip Boehme, Susanne Homann, et al.
European Journal of Applied Physiology|November 22, 2017
New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventionsThomas Mondritzki, Philip Boehme, Lena Schramm, et al.
Journal of Cardiovascular Pharmacology|July 6, 2019
Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor AntagonistPeter Kolkhof, Elisabeth Pook, Mira Pavkovic, et al.
Pageof 4